Commercial Insurer Accountability

After concerns raised by the AHA and other health groups, UnitedHealthcare today announced that it would delay until the end of the COVID-19 public health emergency its recently-announced policy that would have retroactively denied coverage for emergency department claims the insurer deemed non-…
AHA urged UnitedHealthcare to reverse its decision to retroactively deny coverage effective July 1 for emergency department claims the insurer deems non-emergent.
America’s hospitals and health systems are deeply concerned by UnitedHealthcare’s (UHC) recent policy announcement to allow for the retroactive denial of coverage for emergency-level care in facilities. This policy would put patients’ health and wellbeing in jeopardy, and we urge you to reverse the…
The AHA expresses concern to UnitedHealthcare regarding its recent policy announcement to allow for the retroactive denial of coverage for emergency-level care in facilities.
AHA and the National Independent Laboratory Association flagged for the National Association of Insurance Commissioners deeply concerning actions by UnitedHealthcare to implement a “misleading” new benefit plan design that will limit access to needed laboratory services.
Letter to Centers for Medicare & Medicaid Services, expressing deep concerns regarding a series of UnitedHealthcare health plan coverage policies.
UnitedHealthcare has delayed from April 1, 2021, until Jan. 1, 2022, its requirement that certain in-network laboratories report their unique laboratory-specific codes along with other information for the overwhelming majority of freestanding and outpatient laboratory testing services.
The AHA today urged UnitedHealthcare to forgo a new coverage policy for laboratory tests that the association believes is burdensome and negatively impacts patients’ access to care.
This letter expresses AHA’s concern about a forthcoming UnitedHealthcare change in coverage policy for laboratory test services.
UnitedHealth Group will accelerate nearly $2 billion in claims payments to U.S. health care providers under its fully insured commercial, Medicare Advantage and Medicaid businesses to address short-term financial pressure caused by the COVID-19 emergency, UnitedHealthcare and Optum announced.